Parkinson’s patients treated with a groundbreaking new therapy to regrow their brain cells have criticised a decision by regulators to stop trials as ‘sinful.’
In the biggest surgical trial ever for the disease, British patients had holes drilled into the heads and special ports implanted so that a naturally occurring protein could be infused directly into the brain over nine months.
Described as ‘Baby Bio’ for brain cells, the Glial Cell Line Derived Neurotrophic Factor (GDNF) encourages the growth of cells that produce dopamine, a crucial hormone needed for movement, which vanishes in Parkinson’s patients.
Read more
Comments are closed.